Recently, the international organization Treatment Action Group (TAG) released the '2023 Tuberculosis Diagnostic Pipeline Report', and Difei Medical's planned tuberculosis diagnostic product 'RAPID TB' was selected as a decentralized testing solution.RAPID TB uses tongue swabs or sputum samples to rapidly diagnose tuberculosis and rifampicin and isoniazid resistance, providing active help for the rapid diagnosis and treatment of tuberculosis patients.

The third IND2023 Infectious Diseases Advanced Molecular Diagnostic Technology Application Forum was held grandly in Shanghai.More than a thousand experts and elite representatives from the in vitro molecular diagnostics industry from major hospitals, testing centers and companies gathered in Shanghai to discuss many hot issues in the field of infectious diseases.